Cited by

• Screening for Pulmonary Hypertension in Systemic Sclerosis-A Primer for Cardio-Rheumatology Clinics.

  Giucă A, Mihai C, Jurcuț C, Gheorghiu AM, Groșeanu L, Dima A, Săftoiu A, Coman IM, Popescu BA, Jurcuț R. Giucă A, et al. Diagnostics (Basel). 2021 Jun 1;11(6):1013. doi: 10.3390/diagnostics11061013. Diagnostics (Basel). 2021. PMID: 34206055 Free PMC article. Review.
• Pulmonary hypertension in systemic sclerosis with usual interstitial pneumonia.

  Carbone RG, Monselise A, Barisione E, Fontana V, Paredi P, Puppo F. Carbone RG, et al. Intern Emerg Med. 2023 Jun;18(4):1087-1093. doi: 10.1007/s11739-023-03267-y. Epub 2023 Apr 17. Intern Emerg Med. 2023. PMID: 37069417
• Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

  Lammi MR, Baughman RP, Birring SS, Russell AM, Ryu JH, Scholand M, Distler O, LeSage D, Sarver C, Antoniou K, Highland KB, Kowal-Bielecka O, Lasky JA, Wells AU, Saketkoo LA. Lammi MR, et al. Curr Respir Med Rev. 2015;11(2):163-174. doi: 10.2174/1573398X11666150619183527. Curr Respir Med Rev. 2015. PMID: 27019654 Free PMC article.
• Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers.

  Castellví I, Simeón CP, Sarmiento M, Casademont J, Corominas H, Fonollosa V. Castellví I, et al. PLoS One. 2020 Dec 10;15(12):e0243651. doi: 10.1371/journal.pone.0243651. eCollection 2020. PLoS One. 2020. PMID: 33301540 Free PMC article.
• Independent Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.

  Barkhane Z, Nimerta F, Zulfiqar S, Dar S, Afzal MS, Zaree A, Adwani R, Palleti SK. Barkhane Z, et al. Cureus. 2023 May 30;15(5):e39730. doi: 10.7759/cureus.39730. eCollection 2023 May. Cureus. 2023. PMID: 37398831 Free PMC article. Review.